OxiWear, a pioneering company in wearable health technology, is proud to announce that it has received clearance from the U.S. Food and Drug Administration (FDA) for its cutting-edge oxygen data collection device. This certification marks a significant milestone in OxiWear’s mission to revolutionize patient care and enhance the quality of life for individuals with chronic diseases.
OxiWear is a cutting-edge ear pulse oximeter designed for continuous, real-time measurement of blood oxygen saturation (SpO2) and pulse rate. This device provides unmatched accuracy and convenience while still and during motion, across all skin types, within clinical and home environments. Unlike traditional methods, OxiWear ensures that patients and healthcare providers have constant access to important oxygen saturation data. The continuous data collection capability is vital for the early detection of low oxygen levels, offering prompt haptic and emergency messaging alerts that can potentially save lives.
“We are thrilled to receive FDA clearance for our OxiWear device,” said Shavini Fernando, CEO of OxiWear. “This validation from the FDA underscores the rigorous testing and development that our team has undertaken to ensure the highest standards of safety and efficacy. Our goal is to provide a reliable, user-friendly solution that empowers patients and supports healthcare professionals in delivering optimal care.”
OxiWear’s device is designed with patient comfort and ease of use in mind. The lightweight, non-invasive wearable can be seamlessly integrated into daily life, providing continuous data collection without disrupting activities. It features advanced sensor technology and wireless connectivity, enabling data to be easily transmitted to healthcare providers for ongoing assessment and management.
Dr. Panagis Galiatsatos, MD, MHS, Associate Professor of Medicine in the Division of Pulmonary & Critical Care Medicine at Johns Hopkins University Hospital, stated, “This device will save lives; both in the sense of picking up low oxygen levels, and ensuring the quality of life that so many patients lose when they need to measure their oxygen level is preserved. For me, as a physician, recommending OxiWear will be a game changer for my patients, and watching them enjoy life as they measure their oxygen levels confidently and responsibly, reaffirms my passion in medicine and doctoring.”
The FDA clearance paves the way for OxiWear to expand its market share for its innovative technology. The company is committed to continuing its research and development efforts to expand the capabilities of its platform and address a broader range of health monitoring needs.
